menu search

Children's medicine face supply shortages as demand spikes

Erin Fox, senior pharmacy director at University of Utah Health, joins 'The Exchange' to discuss the current shortage in children's pain medicine, the...

December 23, 2022, 3:01 pm

Intercept resubmits new drug application to u.s. fda for obeticholic acid in patients with liver fibrosis due to nash

NDA supported by robust NASH clinical development program, including two positive interim analyses from the Phase 3 REGENERATE study NDA includes deta...

December 23, 2022, 12:50 pm

Outlook therapeutics announces $25 million registered direct offering priced at-the-market under nasdaq rules

ISELIN, N.J., Dec. 23, 2022 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutica...

December 23, 2022, 11:00 am

Voyageur pharmaceuticals closes first tranche of c$650,000 private placement

Voyageur pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF) announced the completion of the first tranche of a p...

December 23, 2022, 10:39 am

You can boost your passive income with these 3 dividend raises

A trio of top companies in the agricultural machinery, waste removal, and pharmaceutical industries rec...

December 23, 2022, 9:02 am

Madrigal pharmaceuticals: upcoming windfall profits

Like an early Christmas/Hanukkah present, Madrigal shares rallied over 268% in one session due to the positive MAESTRO-NASH data. The shares continue ...

December 23, 2022, 8:31 am

Why madrigal pharmaceuticals was a top stock this week

Biotech bulls stampeded the company following its latest clinical update....

December 23, 2022, 7:03 am

Seagen: 2023 shaping up to be a breakout year

SGEN has been under pressure since a rumored takeover deal by pharmaceutical giant Merck & Co. fell thr...

December 22, 2022, 5:31 pm

Bioxcel therapeutics to present at 41st annual j.p. morgan healthcare conference

NEW HAVEN, Conn., Dec. 22, 2022 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceu...

December 22, 2022, 12:00 pm

Merck, sichuan kelun enter cancer collaboration, with milestone payments up to $9.3 billion

Merck & Co. Inc. MRK, -0.34% said Thursday that it entered into an agreement with Sichuan Kelun pharmaceutical...

December 22, 2022, 9:41 am

Oric's stock rallies on multiple myeloma deal with pfizer

Shares of Oric pharmaceuticals Inc. ORIC, +2.04% soared about 56% in premarket trading on Thursday, the...

December 22, 2022, 8:38 am

Oric pharmaceuticals (oric) stock rockets 58% on pfizer deal

ORIC pharmaceuticals (NASDAQ: ORIC ) stock is rocketing higher after the company revealed a collaborati...

December 22, 2022, 8:25 am

Harmony biosciences to present at the 41st annual j.p. morgan healthcare conference

PLYMOUTH MEETING, Pa. , Dec. 22, 2022 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a ...

December 22, 2022, 8:05 am

Okyo pharma receives us fda license to start phase 2 study

OKYO Pharma Ltd (LSE:OKYO, NASDAQ:OKYO) said its dry eye disease treatment has received its investigational new drug (IND) application from the US Fo...

December 22, 2022, 2:57 am

Angion receives nasdaq notice regarding minimum bid price requirements

UNIONDALE, N.Y., Dec. 21, 2022 (GLOBE NEWSWIRE) — Angion Biomedica Corp (NASDAQ:ANGN), a biopharmaceutical...

December 22, 2022, 2:50 am

Immupharma says it has ‘clear objective' to advance lupus treatment to next clinical trial in 2023

ImmuPharma PLC (AIM:IMM, OTC:IMMPF) has expressed optimism about 2023, during which it aims to progress its lupus treatment Lupuzor to its next clinic...

December 22, 2022, 2:46 am

Oric pharmaceuticals announces clinical development collaboration with pfizer for oric-533 in multiple myeloma and concurrent $25 million equity investment by pfizer

ORIC and Pfizer have entered into a clinical development collaboration for a Phase 2 study of ORIC-533 in combination with elranatamab in multiple mye...

December 21, 2022, 10:48 pm

Eagle pharmaceuticals to present at the 41st annual j.p. morgan healthcare conference

WOODCLIFF LAKE, N.J., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Eagle pharmaceuticals, Inc. (Nasdaq: EGRX) (“...

December 21, 2022, 4:30 pm

Arrowhead pharmaceuticals to present at 41st annual j.p. morgan healthcare conference

PASADENA, Calif.--( BUSINESS WIRE )--Arrowhead pharmaceuticals Inc. (NASDAQ: ARWR) today announced that...

December 21, 2022, 4:00 pm

Growth, innovation could fuel pharma etf rebound

For much of 2020 and 2021, the pharmaceutical stock investment thesis revolved around development and d...

December 21, 2022, 12:31 pm


Search within

Pages Search Results: